Down-regulation of O6-methylguanine-DNA methyl transferase enhances the effect of temozolomide in melanoma cells

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 147-148

  Jiang, Guan ^a,b   Zheng, Jun Nian ^b   Liu, Yan Qun ^b  

^a Center for Disease Control and Prevention of Xuzhou City   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

CANCER RESISTANCE; COMBINATION CHEMOTHERAPY; CYTOTOXICITY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; LETTER; MELANOMA; MELANOMA CELL; NONHUMAN; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; DACARBAZINE; DOWN-REGULATION; HUMANS; MELANOMA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 78650173536     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.09.024     Document Type: Letter

References (10)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66.
2. Augustine C.K., Yoo J.S., Potti A., et al. Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res 2009, 15(2):502-510.
3. Plummer E.R., Middleton M.R., Jones C., et al. Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly (ADP-ribose) polymerase-1. Clin Cancer Res 2005, 11(9):3402-3409.
4. Kato T, Natsume A, Toda H, et al. Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Gene Ther doi:10.1038/gt.2010.88.
5. Rosati S.F., Williams R.F., Nunnally L.C., et al. IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression. Mol Cancer Ther 2008, 7(12):3852-3858.
6. Wedge S.R., Porteous J.K., Newlands E.S. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model. Cancer Chemother Pharmacol 1997, 40(3):266-272.
7. Emdad L., Lebedeva I.V., Su Z.Z., et al. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol Ther 2009, 8(5):391-400.
8. Zheng M., Bocangel D., Ramesh R., et al. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells. Mol Cancer Ther 2008, 7(12):3842-3851.
9. Qian W., Liu J., Tong Y., et al. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis. Leukemia 2008, 22(2):361-369.
10. Jiang G., Liu Y.Q., Wei Z.P., Pei D.S., Mao L.J., Zheng J.N. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Cancer Lett 2010, 294(2):220-228.